Shinhung Co., Ltd (KRX:004080)
14,500
+10 (0.07%)
Feb 21, 2025, 9:00 AM KST
Shinhung Revenue
Shinhung had revenue of 23.84B KRW in the quarter ending September 30, 2024, a decrease of -13.14%. This brings the company's revenue in the last twelve months to 103.84B, down -9.08% year-over-year. In the year 2023, Shinhung had annual revenue of 112.44B, down -4.85%.
Revenue (ttm)
103.84B
Revenue Growth
-9.08%
P/S Ratio
1.32
Revenue / Employee
519.19M
Employees
200
Market Cap
136.92B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 112.44B | -5.73B | -4.85% |
Dec 31, 2022 | 118.18B | -8.68B | -6.84% |
Dec 31, 2021 | 126.85B | 10.20B | 8.74% |
Dec 31, 2020 | 116.65B | -6.36B | -5.17% |
Dec 31, 2019 | 123.01B | 1.47B | 1.21% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,364.39B |
Celltrion | 2,876.25B |
SK Biopharmaceuticals | 511.33B |
Yuhan | 2,008.84B |
SK bioscience | 201.30B |
Hanmi Pharm. | 1,495.50B |
Hanall Biopharma | 134.24B |
Hanmi Science | 1,283.65B |